Innovative Cancer Diagnostic Technologies and EmergingMarketsReport Details:Published:November 2012No. of Pages: 1200Price...
4. Prostate Cancer5. Stomach Cancer6. Leukemia7. Lymphoma8. Oral Cancer9. Skin Cancer10. Uterine Cancer11. Ovarian Cancer1...
AIB1BCL-2BRCA1CD44C-fosC-mybC-mycCYP-17Erb-BHPC1N-mycP40P51P53PIK3CAPTI-1RasRegSisSrc28. Polypeptide Growth FactorsBasic F...
N-AcetylglucosamineActinAlpha-ActinAntineuronal Antibodies7B2B72.3BaxBCD-F9BLCA-4Blood Group Antigens A,B,HCA 50CA 72-4/TA...
Cytokeratins/CK18/Cyfra 21-1DesminGliofibrillary Acid ProteinNeurofilamentsVimentinKA 93KinasesKP16D3LAILeukocyte Common A...
TachykininTAG 12TPSTroponinTubulinVCAMVEGFVillenC. Instrumentation Review AndMarket Needs1. Abbott AxSYM2. Abbott Architec...
D. Current and Emerging Technologies1. Monoclonal and Polyclonal Antibodies2. Immunoassaysa. Technological Principleb. Rad...
g. Chromosomal Translocation and Oncogenes5. Artificial Intelligence6. Flow Cytometry7. Two Dimensional Gel Electrophoresi...
A. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth and Major SuppliersU.S.A.A. Executive...
C. University ContractsD. Distribution Strategies1. Marketing Approaches2. Product Complexity3. Customer Preference4. Esta...
HologicIpsogenKreatechKyowa MedexLife TechnologiesMackay Life SciencesMyriad GeneticsNanogen ElitechOncoLabOtho-Clinical D...
Major Companies Developing or MarketingBeta-2 Microglobulin TestsMajor Companies Developing or MarketingCA 15-3/27.29 Test...
Oncogene TestsGrowth Factors Potential ApplicationsIn Cancer DiagnosisColony Stimulating Factors PotentialApplications in ...
Diagnostics Sales Forecast by Market SegmentFrance, CA 15-3/27.29 Test Volume andDiagnostics Sales Forecast by MarketSegme...
SegmentFrance, NSE Test Volume and DiagnosticsSales Forecast by Market SegmentFrance, Nucleolar Test Volume and Diagnostic...
And Diagnostics Sales Forecast byMarket SegmentFrance, Thyroglobulin Test Volume andDiagnostics Sales Forecast by MarketSe...
Tumor Marker Test Volume Forecast byTestGermany, Commercial/Private LaboratoriesMajor Tumor Marker Test VolumeForecastGerm...
SegmentGermany, Cytokeratins Test Volume andDiagnostics Sales Forecast by MarketSegmentGermany, Estrogen Receptor Test Vol...
And Diagnostics Sales Forecast by MarketSegmentGermany, PAP Test Volume and DiagnosticsSales Forecast by Market SegmentGer...
Executive Summary Table: Italy, Total TumorMarker Test Volume and Diagnostics SalesForecast by Market SegmentItaly, Estima...
Italy, CA 125 Test Volume and DiagnosticsSales Forecast by Market SegmentItaly, Calcitonin Test Volume and DiagnosticsSale...
SegmentItaly, Progesterone Receptor Test Volume andDiagnostics Sales Forecast by MarketSegmentItaly, PAP Test Volume and D...
Japan, Laboratories Performing TumorMarker Tests by Market SegmentJapan, Hospital Laboratories PerformingTumor Marker Test...
Sales Forecast by Market SegmentJapan, Chromogranin Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, Colon...
SegmentJapan, Pancreatic Oncofetal AntigenTest Volume and DiagnosticsSales Forecast by Market SegmentJapan, PAP Smear Test...
Sales by Major SupplierJapan, CA 15-3/27.29 Testing MarketDiagnostics Sales by Major SupplierJapan, CA 19-9 Testing Market...
Spain, AFP Test Volume and Diagnostics SalesForecast by Market SegmentSpain, Beta-2 Microglobulin Test Volume andDiagnosti...
Spain, PAP Smear Test Volume andDiagnostics Sales Forecast by MarketSegmentSpain, Parathyroid Hormone Test VolumeAnd Diagn...
Sales by Major SupplierSpain, CA 125 Testing Market DiagnosticsSales by Major SupplierSpain, CEA Testing Market Diagnostic...
U.K., Beta-2 Microglobulin Test Volume andDiagnostics Sales Forecast by MarketSegmentU.K., CA 15-3/27.29 Test Volume andDi...
SegmentU.K., Oncogenes Test Volume andDiagnostics Sales Forecast by MarketSegmentU.K., Pancreatic Oncofetal AntigenTest Vo...
U.K., CEA Testing Market DiagnosticsSales by Major SupplierU.K., PSA Testing Market DiagnosticsSales by Major SupplierExec...
TestU.S., Physician Offices/Group PracticesMajor Tumor Marker Sales Forecast byTestU.S., Cancer Clinics Major TumorMarker ...
Sales Forecast by Market SegmentU.S., HCG Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., Insulin Test Vo...
Sales Forecast by Market SegmentU.S., Sialic Acid Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., Squamou...
U.S., Progesterone Receptor Testing MarketDiagnostics Sales by Major SupplierU.S., PSA Testing Market DiagnosticsSales by ...
Upcoming SlideShare
Loading in …5
×

Innovative Cancer Diagnostic Technologies and Emerging Markets

276 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
276
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
4
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Innovative Cancer Diagnostic Technologies and Emerging Markets

  1. 1. Innovative Cancer Diagnostic Technologies and EmergingMarketsReport Details:Published:November 2012No. of Pages: 1200Price: Single User License – US$23700Available by country and section. This comprehensive seven-country report identifies andevaluates major business opportunities emerging in the cancer diagnostics market during the nextten years; examines trends in the U.S., five major European countries (France, Germany, Italy,Japan, UK) and Japan; reviews current and emerging tests; analyzes potential applications ofvarious diagnostic technologies; forecasts sales of major tumor markers by country and marketsegment; profiles leading market players and potential entrants; and suggests alternative businessexpansion strategies for suppliers. The cancer diagnostics market is on the verge of explosion, asthe researchers approach major technological breakthroughs in tumor diagnosis and therapy,discover new specific antigens, and unlock the mystery of the genetic basis of the disease. Duringthe next ten years, the worldwide cancer testing market is promising to be an exciting, dynamicand rapidly expanding field. Anticipated technological breakthroughs will create numerousopportunities for determining genetic predisposition, detecting specific tumors, and monitoringbiological response to cancer therapy. The rise in geriatric population will further compound thegrowing demand for malignancy assays and the rapid market expansion worldwide.Get your copy of this report @http://www.reportsnreports.com/reports/205878-innovative-cancer-diagnostic-technologies-and-emerging-markets.htmlMajor points covered in Table of Contents of this report includeTable of ContentsIntroductionWorldwide Market and Technology OverviewA. Cancer Statistics and Etiology1. Brest Cancer2. Lung Cancer3. Colon and Rectum Cancer
  2. 2. 4. Prostate Cancer5. Stomach Cancer6. Leukemia7. Lymphoma8. Oral Cancer9. Skin Cancer10. Uterine Cancer11. Ovarian Cancer12. Bladder CancerB. Major Current And Emerging Cancer Diagnostic Tests1. Introduction2. Tumor Marker Classification3. ACTH4. Alpha-Fetoprotein (AFP)5. Beta-2 Microglobulin6. CA 15-3/27.297. CA 19-98. CA-1259. Calcitonin10. Carcinoembrionic Antigen (CEA)11. Estrogen and Progesterone Receptors12. Ferritin13. Gastrin14. Human Chorionic Gonadotropin (HCG)15. Insulin16. NSE17. Occult Blood18. PAP Smear/HPV19. Prostatic Acid Phosphatase (PAP)20. Prostate-Specific Antigen (PSA)21. Squamous Cell Carcinoma Antigen (SCC)22. T and B Lymphocytes23. TdT24. Thyroglobulin25. Tissue Polypeptide Antigen (TPA)26. Biochemical Tumor MarkersADAB-ProteinPNP5-Nucleotidase27. OncogenesAbl/abl-bcr
  3. 3. AIB1BCL-2BRCA1CD44C-fosC-mybC-mycCYP-17Erb-BHPC1N-mycP40P51P53PIK3CAPTI-1RasRegSisSrc28. Polypeptide Growth FactorsBasic Fibroblast Growth FactorBeta-TGFCachectin (TNT)CalmodulinECFRNerve Growth Factor (NGF)Epidermal Growth Factor (EGF)Ornithine DecarboxylaseTransferrinTransforming Growth Factor-Alpha29. Ectopic Hormones30. Colony Stimulating Factors31. LymphokinesAlpha-InterferonB Cell Growth FactorsB Cell Growth Factor (BCGF)Gamma-InterferonInterleukin-1 (IL-1)Macrophage Activating Factor32. Immunohistochemical Stains33. Emerging Tumor Markers
  4. 4. N-AcetylglucosamineActinAlpha-ActinAntineuronal Antibodies7B2B72.3BaxBCD-F9BLCA-4Blood Group Antigens A,B,HCA 50CA 72-4/TAG-72CA 195CA-242CA-549CAM 26CAR-3Cathepsin-DChromogranin A and BCluster 1 AntigenCluster-5/5A AntigenCTACU18DR-70DU-PAN-2Endometrial Bleeding Associated FactorEndostatinEpithelial Membrane AntigenFeulgen HydrolysisFibronectinFSH(1->3)-L-fucosyltransferaseGastrin-Releasing Peptide (GRP)GDCFP-15GlucagonGlycoaminesH23Her-2Human Carcinoma AntigenHPAHSP27Intermediate Filaments
  5. 5. Cytokeratins/CK18/Cyfra 21-1DesminGliofibrillary Acid ProteinNeurofilamentsVimentinKA 93KinasesKP16D3LAILeukocyte Common AntigenLewis AntigensLysophosphatidic Acid (LPA)Ma 695/Ma 552MABDF3MAGME1MinactivinMN/CA9MSAMucin Cancer Antigen (MCA)Multiple Tumor Suppressor 1MyosinNEA-130NMP22OA-519Opiod PeptidesP-glycoproteinPancreatic Oncofetal Antigen (POA)Placental LactogenPR92Proliferative Index, Ki-67PxRB Inactivation/DeletionRetSCCL 175SelectinSialic AcidSialyl SSEA-1/SLXSN10SomatostatinTA-90TABA
  6. 6. TachykininTAG 12TPSTroponinTubulinVCAMVEGFVillenC. Instrumentation Review AndMarket Needs1. Abbott AxSYM2. Abbott Architect c40003. Abbott Architect i2000 Series4. Abbott Architect ci8200 System5. Beckman Coulter UniCel Series6. Beckman Coulter Access7. Binding Site ESP6008. bioMerieux Mini Vidas9. Carolina Chemistries BioLis 24i10. DiaSorin Liaison11. Horiba ABX Pentra 40012. Inverness DS213. J&J Vitros ECi/ECiQ14. J&J Vitros 360015. J&J Vitros 560016. Olympus AU540017. Olympus AU3000i18. Olympus AU270019. Roche Modular Analytics20. Roche Cobas Integra 40021. Roche Cobas Integra 400 Plus22. Roche Elecsys23. Roche Cobas c31124. Siemens ADVIA Centaur25. Siemens Dimension26. Siemens Dimension RxL Max27. Siemens Dimension Vista 50028. Siemens Immulite29. Siemens Stratus30. Tosoh AIA-Series31. Vital Diagnostics ATAC 800032. Vital Diagnostics Envoy 500
  7. 7. D. Current and Emerging Technologies1. Monoclonal and Polyclonal Antibodies2. Immunoassaysa. Technological Principleb. Radioimmunoassay (RIA)c. Enzyme Immunoassays (EIA)OverviewELISAImmunofiltrationParticle-Membrane Capture ImmunoassayEnzyme Amplificationd. Fluorescent Immunoassayse. LuminescenceChemiluminescenceBioluminescencef. Latex Agglutinationg. ImmunoprecipitationH. Affinity Chromatographue. Liposome Flow-Injection Immunoassay3. Molecular Diagnosticsa. Technology Overviewb. Amplification MethodsPCRDAP-PCRImmuno-PCRQC-PCRCARDNAHPALCRNASBAQBRSDA3 SR, and others4. Chromosome Analysisa. Chronic Myelogenous Leukemia (CML)b. Acute Myeloid Leukemia (AML)c. Acute Lymphoblastic Leukemia (ALL)d. Malignant LymphomasLymphoid Malignanciese. Chronic Lymphocytic Leukemia (CLL)f. Solid Cancers
  8. 8. g. Chromosomal Translocation and Oncogenes5. Artificial Intelligence6. Flow Cytometry7. Two Dimensional Gel Electrophoresis (2-DGE)8. Biosensors9. Competing/Complementing Technologiesa. CTb. MRIc. NMRd. PETe. Photonics SpectroscopyF. Business Environment1. Market Overview2. Worldwide Market Structure3. Worldwide Market Size and GrowthG. Personal TestingFranceA. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth and Major SuppliersGermanyA. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth and Major SuppliersItalyA. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth and Major SuppliersJapanA. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth and Major SuppliersSpainA. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth and Major SuppliersU.K.
  9. 9. A. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth and Major SuppliersU.S.A.A. Executive SummaryB. Business Environment1. Health Care Expenditures2. Cost Consciousness3. Industry Consolidation4. Managed Care5. Hospitals6. Admissions7. Length of Stay8. Industry Diversification9. Physician Demographics10. Population Aginga. Chronic Illnessb. Disease Incidencec. Susceptibility to Iatrogenesisd. Multiple Illness Cases11. Laboratory RegulationsC. Market Structure1. Centralized Testinga. Hospitalsb. Commercial/Private Laboratories2. POT/Decentralized Testinga. Physician Offices/Group Practicesb. Cancer Clinicsc. Point-Of-Care Testingd. Other Decentralized Testing LocationsD. Market Size, Growth and Major Suppliers Sales,Instrument Placements and Market SharesMajor Product Development OpportunitiesA. Reagent Kits and Test Systems/PanelsB. InstrumentationC. Computers, Software and AutomationD. Auxiliary ProductsDesign Criteria for Decentralized Testing ProductsAlternative Market Penetration StrategiesA. Internal DevelopmentB. Collaborative Arrangements
  10. 10. C. University ContractsD. Distribution Strategies1. Marketing Approaches2. Product Complexity3. Customer Preference4. Established Suppliers5. Emerging Suppliers6. Major Types of Distributors7. Market Segmentation FactorPotential Market Entry Barriers and RisksA. Market MaturityB. Cost ContainmentC. CompetitionD. Technological Edge and LimitationsE. Patent ProtectionF. Regulatory ConstraintsG. Decentralized Testing Market ChallengesCompetitive ProfilesAbbottAdnaGenApplied Gene TechnologiesArcaBeckman Coulter/DanaherBecton DickinsonBiomedical DiagnosticsbioMerieuxBio-RadCepheidCorrelogic SystemsDakoDecodeDiadexusDiagnocureDiasorinEiken ChemicalEnterixEnzo BiochemEpigenomicsExact SciencesFujirebioGen-ProbeGuided Therapeutics
  11. 11. HologicIpsogenKreatechKyowa MedexLife TechnologiesMackay Life SciencesMyriad GeneticsNanogen ElitechOncoLabOtho-Clinical DiagnosticsPanacea PharmaceuticalsPolartechnicsPolymedcoPreMDQiagenRadient PharmaceuticalsRocheScienionSequenomSiemens HealthcareTakara BioTargeted Diagnostics & TherapeuticsTosohVeridexWako Pure ChemicalsWallac/PEZilaAppendixesAppendix I: Major Universities and Research Centers Developing Cancer DiagnosticTechnology and ApplicationsAppendix II: Assumed Currency Exchange RatesList of TablesTumor Marker ClassificationMajor Companies Developing or MarketingACTH TestsMajor Companies Developing or MarketingAFP Tests
  12. 12. Major Companies Developing or MarketingBeta-2 Microglobulin TestsMajor Companies Developing or MarketingCA 15-3/27.29 TestsMajor Companies Developing or MarketingCA 19-9 TestsMajor Companies Developing or MarketingCA 125 TestsMajor Companies Developing or MarketingCalcitonin TestsMajor Companies Developing or MarketingCEA TestsMajor Companies Developing or MarketingEstrogen Receptor TestsMajor Companies Developing or MarketingProgesterone Receptor TestsMajor Companies Developing or MarketingFerritin TestsMajor Companies Developing or MarketingGastrin TestsMajor Companies Developing or MarketingHCG TestsMajor Companies Developing or MarketingInsulin TestsMajor Companies Developing or MarketingNSE TestsMajor Companies Developing or MarketingOccult Blood TestsMajor Companies Developing or MarketingPAP Smear/HPV TestsMajor Companies Developing or MarketingPAP TestsMajor Companies Developing or MarketingPSA TestsMajor Companies Developing or MarketingLymphocyte Subclassification TestsBiochemical Markers Potential ApplicationsIn Cancer DiagnosisOncogenes Potential ApplicationsIn Cancer DiagnosisMajor Companies Developing or Marketing
  13. 13. Oncogene TestsGrowth Factors Potential ApplicationsIn Cancer DiagnosisColony Stimulating Factors PotentialApplications in Cancer DiagnosisLymphokines Potential ApplicationsIn Cancer DiagnosisImmunohistochemical Stains PotentialApplications in Cancer DiagnosisExecutive Summary Table: France, Total CancerDiagnostic Test Volume and Sales Forecast byMarket SegmentFrance, Estimated Cancer Death RatesPer 100,000 PopulationFrance, Laboratories Performing TumorMarker Tests by Market SegmentFrance, Hospital Laboratories PerformingTumor Marker Tests by Bed SizeFrance, Commercial/Private LaboratoriesPerforming Tumor Markers by AnnualTest VolumeFrance, Total Tumor Marker Test VolumeForecast by Market SegmentFrance, All Market Segments Major TumorMarker Test Volume ForecastFrance, Hospital Laboratories Major TumorMarker Test Volume Forecast by TestFrance, Commercial/Private LaboratoriesMarker Test Volume ForecastFrance, Total Tumor Marker Sales Major TumorForecast by Market SegmentFrance, All Market Segments Major TumorMarker Sales Forecast by TestFrance, Hospital Laboratories Major TumorMarker Sales Forecast by TestFrance, Commercial/Private Laboratories CancerDiagnostics Market Forecast by TestFrance, ACTH Test Volume and Diagnostics SalesForecast by Market SegmentFrance, AFP Test Volume and Diagnostics SalesForecast by Market SegmentFrance, Beta-2 Microglobulin Test Volume and
  14. 14. Diagnostics Sales Forecast by Market SegmentFrance, CA 15-3/27.29 Test Volume andDiagnostics Sales Forecast by MarketSegmentFrance, CA 19-9 Test Volume and DiagnosticsSales Forecast by MarketFrance, CA-125 Test Volume and DiagnosticsSales Forecast by Market SegmentFrance, Calcitonin Test Volume and DiagnosticsSales Forecast by Market SegmentFrance, Cathepsin Test Volume and DiagnosticsSales Forecast by Market SegmentFrance, CEA Test Volume and Diagnostics SalesForecast by Market SegmentFrance, Colon-Specific Antigen Test VolumeAnd Diagnostics Sales Forecast by MarketSegmentFrance, Cytokeratins Test Volume andDiagnostics Sales Forecast by MarketSegmentFrance, Estrogen Receptor Test Volume andDiagnostics Sales Forecast by MarketSegmentFrance, Ferritin Test Volume andDiagnostics Sales Forecast by MarketSegmentFrance, Gastrin Test Volume andDiagnostics Sales Forecast by MarketSegmentFrance, HCG Test Volume and Diagnostics SalesForecast by Market SegmentFrance, Insulin Test Volume andDiagnostics Sales Forecast by MarketSegmentFrance, Interferons Test Volume andDiagnostics Sales Forecast by MarketSegmentFrance, Interleukins Test Volume andDiagnostics Sales Forecast by MarketSegmentFrance, Lymphocyte Subtyping Test VolumeAnd Diagnostics Sales Forecast by Market
  15. 15. SegmentFrance, NSE Test Volume and DiagnosticsSales Forecast by Market SegmentFrance, Nucleolar Test Volume and DiagnosticsSales Forecast by Market SegmentFrance, Occult Blood Test Volume andDiagnostics Sales Forecast by MarketSegmentFrance, Oncogenes Test Volume andDiagnostics Sales Forecast by MarketSegmentFrance, Pancreatic Oncofetal AntigenTest Volume and Diagnostics SalesForecast by Market SegmentFrance, PAP Smear Test Volume andDiagnostics Sales Forecast by MarketSegmentFrance, Parathyroid Hormone Test Volume andDiagnostics Sales Forecast by MarketSegmentFrance, Progesterone Receptor Test VolumeAnd Diagnostics Sales Forecast by MarketSegmentFrance, PAP Test Volume and Diagnostics SalesForecast by Market SegmentFrance, PSA Test Volume and Diagnostics SalesForecast by Market SegmentFrance, S-100 Protein Test Volume and SalesDiagnostics Sales Forecast by MarketSegmentFrance, Serotonin Test Volume andDiagnostics Sales Forecast by MarketSegmentFrance, Sialic Acid Test Volume andDiagnostics Sales Forecast by MarketSegmentFrance, Squamous Cell Carcinoma AntigenTest Volume and Diagnostics SalesForecast by Market SegmentFrance, TDT Test Volume and Diagnostics SalesForecast by Market SegmentFrance, Thymidine Kinase Test Volume
  16. 16. And Diagnostics Sales Forecast byMarket SegmentFrance, Thyroglobulin Test Volume andDiagnostics Sales Forecast by MarketSegmentFrance, TPA Test Volume and Diagnostics SalesForecast by Market SegmentFrance, Total Tumor Marker SalesBy Major SuppliersFrance, AFP Testing Market DiagnosticsSales by Major SupplierFrance, CA 15-3 Testing Market DiagnosticsSales by Major SupplierFrance, CA 19-9 Testing Market DiagnosticsSales by Major SupplierFrance, CA 125 Testing Market DiagnosticsSales by Major SupplierFrance, CEA Testing Market DiagnosticsSales by Major SupplierFrance, NSE Testing Market DiagnosticsSales by Major SupplierFrance, PAP Testing Market DiagnosticsSales by Major SupplierFrance, PSA Testing Market DiagnosticsSales by Major SupplierExecutive Summary Table: Germany, TotalTumor Marker Test Volume and Sales ForecastBy Market SegmentGermany, Estimated Cancer Death RatesPer 100,000 PopulationGermany, Laboratories Performing TumorMarker Tests by Market SegmentGermany, Hospital Laboratories PerformingTumor Marker Tests by Bed SizeGermany, Commercial/Private LaboratoriesPerforming Tumor Markers by AnnualTest VolumeGermany, Total Tumor Marker Test VolumeForecast by Market SegmentGermany, All Market Segments, Major TumorMarker Test Volume ForecastGermany, Hospital Laboratories, Major
  17. 17. Tumor Marker Test Volume Forecast byTestGermany, Commercial/Private LaboratoriesMajor Tumor Marker Test VolumeForecastGermany, Physician Offices/GroupPractices Major Tumor MarkerTest Volume ForecastGermany, Total Tumor Marker SalesForecast by Market SegmentGermany, All Market Segments Major TumorMarker Sales Forecast by TestGermany, Hospital Laboratories, Major TumorMarker Sales Forecast by TestGermany, Commercial/Private LaboratoriesMajor Tumor Marker Sales Forecast by TestGermany, Physician Offices/Group PracticesMajor Tumor Marker Sales Forecast by TestGermany, ACTH Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, AFP Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, Beta-2 Microglobulin Test VolumeAnd Diagnostics Sales Forecast by MarketSegmentGermany, CA-15-3/27.29 Test Volume andDiagnostics Sales Forecast by Market SegmentGermany, CA-19 Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, CA 125 Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, Calcitonin Test VolumeAnd Diagnostic Sales Forecast by MarketSegmentGermany, Cathepsin Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, CEA Test Volume and Diagnostics SalesForecast by Market SegmentGermany, Chromogranin Test VolumeAnd Diagnostics Sales Forecast by Market SegmentGermany, Colon-Specific Antigen Test VolumeAnd Diagnostics Sales Forecast by Market
  18. 18. SegmentGermany, Cytokeratins Test Volume andDiagnostics Sales Forecast by MarketSegmentGermany, Estrogen Receptor Test Volume andDiagnostics Sales Forecast by MarketSegmentGermany, Ferritin Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, Gastrin Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, HCG, Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, Insulin Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, Interferons Test Volume andDiagnostics Sales Forecast by MarketSegmentGermany, Interleukins Test Volume andDiagnostics Sales Forecast by MarketSegmentGermany, Lymphocyte Subtyping Test Volume andDiagnostics Sales Forecast by MarketSegmentGermany, NSE Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, Occult Blood Test Volume andDiagnostics Sales Forecast by MarketSegmentGermany, Oncogenes Test Volume andDiagnostics Sales Forecast by MarketSegmentGermany, Pancreatic Oncofetal AntigenTest Volume and Diagnostics SalesForecast by Market SegmentGermany, Pap Smear Test Volume andDiagnostics Sales Forecast by MarketSegmentGermany, Parathyroid Hormone Test Volume andDiagnostics Sales Forecast by MarketSegmentGermany, Progesterone Receptor Test Volume
  19. 19. And Diagnostics Sales Forecast by MarketSegmentGermany, PAP Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, PSA Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, S-100 Protein Test Volume andDiagnostics Sales Forecast by MarketSegmentGermany, Serotonin Test Volume andDiagnostics Sales Forecast by MarSegmentGermany, Sialic Acid Test Volume andDiagnostics Sales Forecast by MarketSegmentGermany, Squamous Cell Carcinoma AntigenTest Volume and Diagnostics Sales ForecastBy Market SegmentGermany, TDT Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, Thymidine Kinase Test Volume andDiagnostics Sales Forecast by MarketSegmentGermany, Thyroglobulin Test Volume andDiagnostics Sales Forecast by MarketSegmentGermany, TPA Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, Total Tumor Marker SalesBy Major SupplierGermany, AFP Testing Market DiagnosticsSales by Major SupplierGermany CA 15-3/27.29 Testing MarketDiagnostics Sales by Major SupplierGermany CA 19-9 Testing Market DiagnosticsSales by Major SupplierGermany, CA 125 Testing Market DiagnosticsSales by Major SupplierGermany, CEA Testing Market DiagnosticsSales by Major SupplierGermany, PSA Testing Market DiagnosticsSales by Major Supplier
  20. 20. Executive Summary Table: Italy, Total TumorMarker Test Volume and Diagnostics SalesForecast by Market SegmentItaly, Estimated Cancer Death RatesPer 100,000 PopulationItaly, Laboratories Performing TumorMarker Tests by Market SegmentItaly, Hospital Laboratories PerformingTumor Marker Tests by Bed SizeItaly, Commercial/Private LaboratoriesPerforming Tumor Markers by AnnualTest VolumeItaly, Total Tumor Marker Test VolumeForecast by Market SegmentItaly, All Market Segments Major CancerDiagnostic Test Volume ForecastItaly, Hospital Laboratories Major TumorMarker Test Volume ForecastItaly, Commercial/Private LaboratoriesMajor Tumor Marker Test VolumeForecastItaly, Total Tumor Marker Test MarketForecast by Market SegmentItaly, All Market Segments Major TumorMarker Sales Forecast by TestItaly, Hospital Laboratories MajorTumor Marker Forecast by TestItaly, Commercial/Private LaboratoriesMajor Tumor Marker Sales Forecast byTestItaly, ACTH Test Volume and DiagnosticsSales Forecast by Market SegmentItaly, AFP Test Volume and DiagnosticsSales Forecast by Market SegmentItaly, Beta-2 Microglobulin Test VolumeAnd Diagnostics Sales Forecast byMarket SegmentItaly, CA 15-3/27.29 Test Volume andDiagnostics Sales Forecast by MarketSegmentItaly, CA-19-9 Test Volume and DiagnosticsSales Forecast by Market Segment
  21. 21. Italy, CA 125 Test Volume and DiagnosticsSales Forecast by Market SegmentItaly, Calcitonin Test Volume and DiagnosticsSales Forecast by Market SegmentItaly, CEA Test Volume and Diagnostics SalesForecast by Market SegmentItaly, Chromogranin Test VolumeAnd Diagnostics Sales Forecast by Market SegmentItaly, Colon Specific Antigen Test VolumeAnd Diagnostics Sales Forecast by MarketSegmentItaly, Cytokeratins Test Volume andDiagnostics Sales Forecast by MarketSegmentItaly, Estrogen Receptor Test Volume andDiagnostics Sales Forecast by MarketSegmentItaly, Ferritin Test Volume and DiagnosticsSales Forecast by Market SegmentItaly, Gastrin Test Volume and DiagnosticsSales Forecast by Market SegmentItaly, HCG Test Volume and DiagnosticsSales Forecast by Market SegmentItaly, Insulin Test Volume and DiagnosticsSales Forecast by Market SegmentItaly, Lymphocyte Subtyping Test VolumeAnd Diagnostics Sales Forecast by MarketSegmentItaly, NSE Test Volume and Diagnostics SalesForecast by Market SegmentItaly, Occult Blood Test Volume and DiagnosticsSales Forecast by Market SegmentItaly, Oncogenes Test Volume and DiagnosticsSales Forecast by Market SegmentItaly, Pancreatic Oncofetal Antigen TestVolume and Diagnostics Sales Forecast byMarket SegmentItaly, PAP Smear Test Volume andDiagnostics Sales Forecast by MarketSegmentItaly, Parathyroid Hormone Test Volume andDiagnostics Sales Forecast by Market
  22. 22. SegmentItaly, Progesterone Receptor Test Volume andDiagnostics Sales Forecast by MarketSegmentItaly, PAP Test Volume and Diagnostics SalesForecast by Market SegmentItaly, PSA Test Volume and Diagnostics SalesForecast by Market SegmentItaly, S-100 Test Volume and DiagnosticsSales Forecast by Market SegmentItaly, Serotonin Test Volume andDiagnostics Sales Forecast by MarketSegmentItaly, Sialic Acid Test Volume andDiagnostics Sales Forecast by MarketSegmentItaly, Squamous Cell Carcinoma Antigen TestVolume and Diagnostics Sales Forecast byMarket SegmentItaly, TDT Test Volume and Diagnostics SalesForecast by Market SegmentItaly, Thymidine Kinase Test Volume andDiagnostics Sales Forecast by MarketSegmentItaly, Thyroglobulin Test Volume andDiagnostics Sales Forecast by MarketSegmentItaly, TPA Test Volume and Diagnostics SalesForecast by Market SegmentItaly, Total Tumor MarkersSales by Major SuppliersItaly, AFP Testing Market DiagnosticsSales by Major SupplierItaly, CEA Testing Market DiagnosticsSales by Major SupplierItaly, PSA Testing Market DiagnosticsSales by Major SupplierExecutive Summary Table: Japan, Total TumorMarker Test Volume and Sales Forecast byMarket SegmentJapan, Estimated Cancer Death RatesPer 100,000 Population
  23. 23. Japan, Laboratories Performing TumorMarker Tests by Market SegmentJapan, Hospital Laboratories PerformingTumor Marker Tests by Bed SizeCommercial/Private LaboratoriesPerforming Tumor Marker TestsBy Annual Test VolumeJapan, Total Tumor Marker Testing VolumeForecast by Market SegmentJapan, All Market Segments Major TumorMarker Test Volume ForecastJapan, Hospital Laboratories Major TumorMarker Test Volume Forecast by TestJapan, Commercial/Private Laboratories MajorTumor Marker Test Volume ForecastJapan, Total Tumor Marker SalesForecast by Market SegmentJapan, All Market Segments Major TumorMarker Sales Forecast by TestJapan, Hospital Laboratories Major TumorMarker Sales Forecast by TestJapan, Commercial/Private Laboratories MajorTumor Marker Sales Forecast by TestJapan, ACTH Test Volume and Diagnostics SalesForecast by Market SegmentJapan, AFP Test Volume and Diagnostics SalesForecast by Market SegmentJapan, Beta-2 Microglobulin Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, CA 15-3/27.29 Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, CA 19-9 Test Volume and DiagnosticsSales Forecast by Market SegmentJapan, CA-125 Test Volume and DiagnosticsSales Forecast by Market SegmentJapan, Calcitonin Test Volume and DiagnosticsSales Forecast by Market SegmentJapan, Cathepsin Test Volume and DiagnosticsSales Forecast by Market SegmentJapan, CEA Test Volume and Diagnostics
  24. 24. Sales Forecast by Market SegmentJapan, Chromogranin Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, Colon-Specific Antigen Test VolumeAnd Diagnostics Sales Forecast by MarketSegmentJapan, Cytokeratins Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, Estrogen Receptor Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, Ferritin Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, Gastrin Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, HCG Test Volume and Diagnostics SalesForecast by Market SegmentJapan, Insulin Test Volume and DiagnosticsSales Forecast by Market SegmentJapan, Interferons Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, Interleukins Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, Lymphocyte Subtyping Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, NSE Test Volume and Diagnostics SalesForecast by Market SegmentJapan, Nucleolar Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, Occult Blood Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, Oncogenes Test Volume andDiagnostics Sales Forecast by Market
  25. 25. SegmentJapan, Pancreatic Oncofetal AntigenTest Volume and DiagnosticsSales Forecast by Market SegmentJapan, PAP Smear Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, Parathyroid HormoneTest Volume and DiagnosticsSales Forecast by Market SegmentJapan, Progesterone ReceptorTest Volume and DiagnosticsSales Forecast by Market SegmentJapan, PAP Test Volume and Diagnostics SalesForecast by Market SegmentJapan, PSA Test Volume and Diagnostics SalesForecast by Market SegmentJapan, S-100 Protein Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, Serotonin Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, Sialic Acid Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, Squamous Cell Carcinoma AntigenTest Volume and Diagnostics SalesForecast by Market SegmentJapan, TDT Test Volume and DiagnosticsSales Forecast by Market SegmentJapan, Thymidine KinaseTest Volume and DiagnosticsSales Forecast by Market SegmentJapan, ThyroglobulinTest Volume and DiagnosticsSales Forecast by Market SegmentJapan, TPA, Test Volume and DiagnosticsSales Forecast by Market SegmentJapan, Total Tumor MarkerSales by Major SuppliersJapan, AFP Testing Market Diagnostics
  26. 26. Sales by Major SupplierJapan, CA 15-3/27.29 Testing MarketDiagnostics Sales by Major SupplierJapan, CA 19-9 Testing Market DiagnosticsSales by Major SupplierJapan, CA 125 Testing Market DiagnosticsSales by Major SupplierJapan, Calcitonin Testing Market DiagnosticsSales by Major SupplierJapan, PAP Testing Market DiagnosticsSales by Major SupplierJapan, PSA Testing Market DiagnosticsSales by Major SupplierExecutive Summary Table: Spain, TotalTumor Marker Test Volume and SalesForecast by Market SegmentSpain, Estimated Cancer Death RatesPer 100,000 PopulationSpain, Laboratories Performing TumorMarker Tests by Market SegmentSpain, Hospital Laboratories PerformingTumor Marker Tests by Bed SizeSpain, Commercial/Private LaboratoriesPerforming Tumor Markers byAnnual Test VolumeSpain, Total Tumor Marker Test VolumeForecast by Market SegmentSpain, All Market Segment Major CancerDiagnostic Test Volume ForecastSpain, Hospital Laboratories Major CancerDiagnostic Test Volume Forecast byTestSpain, Commercial/Private LaboratoriesMajor Tumor Marker Test Volume ForecastSpain, Total Tumor Marker SalesForecast by Market SegmentSpain, All Market Segments Major TumorMarker Sales Forecast by TestSpain, Hospital Laboratories Major TumorMarker Sales Forecast by TestSpain, Commercial/Private Laboratories MajorTumor Marker Sales Forecast by Test
  27. 27. Spain, AFP Test Volume and Diagnostics SalesForecast by Market SegmentSpain, Beta-2 Microglobulin Test Volume andDiagnostics Sales Forecast by Market SegmentSpain, CA 15-3 Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, CA 19-9 Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, CA-125 Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, Calcitonin Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, CEA Test Volume and Diagnostics SalesForecast by Market SegmentSpain, Colon-Specific Antigen Test Volume andDiagnostics Sales Forecast by MarketSegmentSpain, Estrogen Receptor Test Volume andDiagnostics Sales Forecast by MarketSegmentSpain, Ferritin Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, Gastrin Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, HCG Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, Insulin Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, Lymphocyte SubtypingTest Volume and DiagnosticsSales Forecast by Market SegmentSpain, NSE Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, Occult Blood Test Volume andDiagnostics Sales Forecast by MarketSegmentSpain, Oncogenes Test Volume andDiagnostics Sales Forecast by MarketSegmentSpain, Pancreatic Oncofetal AntigenTest Volume and DiagnosticsSales Forecast by Market Segment
  28. 28. Spain, PAP Smear Test Volume andDiagnostics Sales Forecast by MarketSegmentSpain, Parathyroid Hormone Test VolumeAnd Diagnostics Sales Forecast by MarketSegmentSpain, Progesterone ReceptorTest Volume and Diagnostics Sales Forecastby Market SegmentSpain, PAP Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, PSA Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, S-100 Protein Test VolumeAnd Diagnostics Sales Forecast by MarketSegmentSpain, Serotonin Test Volume andDiagnostics Sales Forecast by MarketSegmentSpain, Sialic Acid Test Volume andDiagnostics Sales Forecast by MarketSegmentSpain, Squamous Cell Carcinoma AntigenTest Volume and Diagnostics Sales Forecastby Market SegmentSpain, TDT Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, Thymidine KinaseTest Volume and DiagnosticsSales Forecast by Market SegmentSpain, ThyroglobulinTest Volume and DiagnosticsSales Forecast by Market SegmentSpain, TPA Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, Total Tumor Marker Sales byMajor SuppliersSpain, AFP Testing Market DiagnosticsSales by Major SupplierSpain, CA 15-3/27.29 Testing MarketDiagnostics Sales by Major SupplierSpain, 19-9 Testing Market Diagnostics
  29. 29. Sales by Major SupplierSpain, CA 125 Testing Market DiagnosticsSales by Major SupplierSpain, CEA Testing Market DiagnosticsSales by Major SupplierSpain, PSA Testing Market DiagnosticsSales by Major SupplierExecutive Summary Table: U.K., TotalTumor Marker Test Volume and SalesForecast by Market SegmentU.K., Estimated Cancer Death RatesPer 100,000 PopulationU.K., Laboratories Performing TumorMarker Tests by Market SegmentU.K., Hospital Laboratories PerformingTumor Marker Tests by Bed SizeU.K., Commercial/Private LaboratoriesPerforming Tumor Marker Tests byAnnual Test VolumeU.K., Total Tumor Marker Testing VolumeForecast by Market SegmentU.K., All Market Segments MajorTumor Marker Test Volume ForecastU.K., Hospital Laboratories MajorTumor Marker Test Volume Forecast byTestU.K., Commercial/Private LaboratoriesMajor Tumor Marker Test VolumeForecastU.K., Total Tumor Marker SalesForecast by Market SegmentU.K., All Market Segments MajorTumor Marker Sales Forecast by TestU.K., Hospital Laboratories MajorTumor Marker Sales Forecast by TestU.K., Commercial/Private LaboratoriesMajor Tumor Marker Sales Forecast byTestU.K., ACTH Test Volume and Diagnostics SalesForecast by Market SegmentU.K., AFP Test Volume and Diagnostics SalesForecast by Market Segment
  30. 30. U.K., Beta-2 Microglobulin Test Volume andDiagnostics Sales Forecast by MarketSegmentU.K., CA 15-3/27.29 Test Volume andDiagnostics Sales Forecast by MarketSegmentU.K., CA 19-9 Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., CA-125 Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Calcitonin Test Volume andDiagnostics Sales Forecast by MarketSegmentU.K., CEA Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Chromogranin Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Colon-Specific Antigen Test VolumeAnd Diagnostics Sales by MarketSegmentU.K., Cytokeratins Test Volume andDiagnostics Sales Forecast by MarketSegmentU.K., Estrogen Receptor Test Volume andDiagnostics Sales Forecast by MarketSegmentU.K., Ferritin Test Volume andDiagnostics Sales Forecast by MarketSegmentU.K., Gastrin Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., HCG Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Insulin Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Lymphocyte Subtyping Test Volume andDiagnostics Sales Forecast by MarketSegmentU.K., NSE Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Occult Blood Test Volume andDiagnostics Sales Forecast by Market
  31. 31. SegmentU.K., Oncogenes Test Volume andDiagnostics Sales Forecast by MarketSegmentU.K., Pancreatic Oncofetal AntigenTest Volume and DiagnosticsSales Forecast by Market SegmentU.K., PAP Smear Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Parathyroid HormoneTest Volume and DiagnosticsSales Forecast by Market SegmentU.K., Progesterone ReceptorTest Volume and DiagnosticsSales Forecast by Market SegmentU.K., PAP Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., PSA Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., S-100 Protein Test Volume andDiagnostics Sales Forecast by MarketSegmentU.K., Serotonin Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Sialic Acid Test Volume andDiagnostics Sales Forecast by MarketSegmentU.K., Squamous Cell Carcinoma AntigenTest Volume and DiagnosticsSales Forecast by Market SegmentU.K., TDT Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Thymidine KinaseTest Volume and DiagnosticsSales Forecast by Market SegmentU.K., ThyroglobulinTest Volume and DiagnosticsSales Forecast by Market SegmentU.K., TPA Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Total Tumor Marker Sales andMarket Shares Forecast
  32. 32. U.K., CEA Testing Market DiagnosticsSales by Major SupplierU.K., PSA Testing Market DiagnosticsSales by Major SupplierExecutive Summary Table: U.S., Total TumorMarker Test Volume and Sales Forecast byMarket SegmentU.S., Estimated New Cancer Cases and DeathsU.S., Estimated Cancer Death RatesPer 100,000 PopulationU.S., Laboratories Performing TumorMarker Tests by Market SegmentU.S., Hospital Laboratories PerformingTumor Marker Tests by Bed SizeU.S., Commercial/Private LaboratoriesPerforming Tumor Marker Tests byAnnual Test VolumeU.S., Physician Office LaboratoriesPerforming Tumor Marker Tests byPractice SizeU.S., Total Tumor Marker Test VolumeForecast by Market Segment-201U.S., All Market Segments MajorTumor Marker Test Volume ForecastU.S., Hospital Laboratories Major TumorMarker Test Volume Forecast by TestU.S., Commercial/Private LaboratoriesMajor Tumor Marker Test VolumeForecastU.S., Physician Offices/Group PracticesMajor Tumor Marker Test VolumeForecastU.S., Cancer Clinics Major TumorMarker Test Volume Forecast by TestU.S., Total Tumor Marker SalesForecast by Market SegmentU.S., All Market Segment Major TumorMarker Sales Forecast by TestU.S., Hospital Laboratories Major TumorMarker Sales Forecast by TestU.S., Commercial/Private LaboratoriesMajor Tumor Marker Sales Forecast by
  33. 33. TestU.S., Physician Offices/Group PracticesMajor Tumor Marker Sales Forecast byTestU.S., Cancer Clinics Major TumorMarker Sales Forecast by TestU.S., ACTH Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., AFP Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., Beta-2 Microglobulin Test Volume andDiagnostics Sales Forecast by MarketSegmentU.S., CA 15-3/27.29 Test Volume andDiagnostics Sales Forecast by MarketSegmentU.S., CA 19-9 Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., CA-125 Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., Calcitonin Test Volume andDiagnostics Sales Forecast by MarketSegmentU.S., Cathepsin Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., CEA Test Volume and DiagnosticsSales by Market SegmentU.S., Chromogranin Test Volume andDiagnostics Sales Forecast by MarketSegmentU.S., Colon-specific Antigen Test Volume andDiagnostics Sales Forecast by MarketSegmentU.S., Cytokeratins Test Volume andDiagnostics Sales Forecast by MarketSegmentU.S., Estrogen Receptor Test Volume andDiagnostics Sales Forecast by MarketSegmentU.S., Ferritin Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., Gastrin Test Volume and Diagnostics
  34. 34. Sales Forecast by Market SegmentU.S., HCG Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., Insulin Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., Interferons Test Volume andDiagnostics Sales Forecast by MarketSegmentU.S., Interleukins Test Volume andDiagnostics Sales Forecast by MarketSegmentU.S., Lymphocyte Subtyping Test Volume andDiagnostics Sales Forecast by MarketSegmentU.S., NSE Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., Nucleolar Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., Occult Blood Test Volume andDiagnostics Sales Forecast by MarketSegmentU.S., Oncogenes Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., Pancreatic Oncofetal AntigenTest Volume and DiagnosticsSales Forecast by Market SegmentU.S., PAP Smear Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., Parathyroid HormoneTest Volume and DiagnosticsSales Forecast by Market SegmentU.S., Progesterone ReceptorTest Volume and DiagnosticsSales Forecast by Market SegmentU.S., PAP Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., PSA Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., S-100 Protein Test Volume andDiagnostics Sales Forecast by MarketSegmentU.S., Serotonin Test Volume and Diagnostics
  35. 35. Sales Forecast by Market SegmentU.S., Sialic Acid Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., Squamous Cell Carcinoma AntigenTest Volume and DiagnosticsSales Forecast by Market SegmentU.S., TDT Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., Thymidine KinaseTest Volume and DiagnosticsSales Forecast by Market SegmentU.S., Thyroglobulin TestVolume and DiagnosticsSales Forecast by Market SegmentU.S., TPA Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., Total Tumor Marker SalesBy Major SupplierU.S., ACTH Testing Market DiagnosticsSales by Major SupplierU.S., AFP Testing Market DiagnosticsSales by Major SupplierU.S., Beta-2 Migroblolulin Testing MarketDiagnostics Sales by Major SupplierU.S., CA 15-3/27.29 Testing MarketDiagnostics Sales by Major SupplierU.S., CA 19-9 Testing Market DiagnosticsSales by Major SupplierU.S., CA 125 Testing Market DiagnosticsSales by Major SupplierU.S., CEA Testing Market DiagnosticsSales by Major SupplierU.S., Ferritin Testing MarketDiagnostics Sales by Major SupplierU.S., HCG Testing MarketDiagnostics Sales by Major SupplierU.S., Insulin Testing MarketDiagnostics Sales by Major SupplierU.S., Parathyroid Hormone Testing MarketDiagnostics Sales by Major SupplierU.S., PAP Testing Market DiagnosticsSales by Major Supplier
  36. 36. U.S., Progesterone Receptor Testing MarketDiagnostics Sales by Major SupplierU.S., PSA Testing Market DiagnosticsSales by Major SupplierContact: sales@reportsandreports.com for more information.

×